Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Director departure
Viveon Health Acquisition Corp. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 10-K Annual Report for the period ended December 31, 2022
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/16/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
05/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/25/2023 8-K Quarterly results
04/06/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/06/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market"
03/31/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
02/28/2023 RW Form RW - Registration Withdrawal Request:
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/03/2023 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "Viveon Health Acquisition Corp."
12/28/2022 425 Form 425 - Prospectuses and communications, business combinations:
12/28/2022 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "As filed Second Amendment to the Company’s Amended and Restated Certificate of Incorporation"
12/22/2022 425 Form 425 - Prospectuses and communications, business combinations:
12/22/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "VIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022. NEW YORK, Dec. 21, 2022 -- Viveon Health Acquisition Corp. , a special purpose acquisition company , today announced that it will allow those holders of shares of the Company’ s common stock sold as part of the units issued in its initial public offering who elected to redeem their common stock in connection with the special meeting of stockholders held today at 10:30 AM EST , to reverse their redemption requests by sending a DTC DWAC request to the Company’ s transfer agent, Continental Stock Transfer & Trust Company, by 5:00 PM EST on Friday, December 23, 2022. In connection with the Spec..."
11/23/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/17/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/15/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/14/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/09/2022 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
09/08/2022 10-Q/A Quarterly Report for the period ended June 30, 2022 [amend]
09/08/2022 10-Q/A Quarterly Report for the period ended March 31, 2022 [amend]
08/24/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
08/19/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/16/2022 8-K Quarterly results
08/15/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/01/2022 SC 13G Feis Lawrence reports a 6.1% stake in Viveon Health Acquisition Corp.
07/13/2022 S-4 Form S-4 - Registration of securities, business combinations:
07/13/2022 8-K Quarterly results
06/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy